vs
Gossamer Bio, Inc.（GOSS）与泛美白银（USAS）财务数据对比。点击上方公司名可切换其他公司
泛美白银的季度营收约是Gossamer Bio, Inc.的1.4倍（$19.1M vs $13.8M），泛美白银净利率更高（-82.3% vs -342.3%，领先260.0%），Gossamer Bio, Inc.同比增速更快（47.1% vs -28.0%）
Gossamer Bio是一家临床阶段生物制药企业，专注于发现、开发和商业化用于治疗免疫、炎症和肿瘤领域重症疾病的创新疗法，推进多条自研候选药物管线进入不同临床阶段，主要面向北美及全球其他地区的医疗市场。
泛美白银是一家总部位于加拿大的矿业企业，业务布局集中在拉丁美洲，在墨西哥、秘鲁、玻利维亚、阿根廷多国持有运营矿山及其他矿产开发项目，是美洲地区重要的贵金属开采企业。
GOSS vs USAS — 直观对比
营收规模更大
USAS
是对方的1.4倍
$13.8M
营收增速更快
GOSS
高出75.2%
-28.0%
净利率更高
USAS
高出260.0%
-342.3%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.8M | $19.1M |
| 净利润 | $-47.2M | $-15.7M |
| 毛利率 | — | 34.2% |
| 营业利润率 | -333.6% | — |
| 净利率 | -342.3% | -82.3% |
| 营收同比 | 47.1% | -28.0% |
| 净利润同比 | -43.0% | 2.8% |
| 每股收益（稀释后） | $-0.21 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GOSSUSAS
| Q4 25 | $13.8M | — | ||
| Q3 25 | $13.3M | $19.1M | ||
| Q3 24 | — | $26.5M | ||
| Q2 24 | $95.8M | — | ||
| Q1 24 | $0 | — | ||
| Q3 23 | $0 | — | ||
| Q2 23 | $0 | — |
净利润GOSSUSAS
| Q4 25 | $-47.2M | — | ||
| Q3 25 | $-48.2M | $-15.7M | ||
| Q3 24 | — | $-16.2M | ||
| Q2 24 | $49.2M | — | ||
| Q1 24 | $-41.9M | — | ||
| Q3 23 | $-40.0M | — | ||
| Q2 23 | $-42.5M | — |
毛利率GOSSUSAS
| Q4 25 | — | — | ||
| Q3 25 | — | 34.2% | ||
| Q3 24 | — | 23.6% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
营业利润率GOSSUSAS
| Q4 25 | -333.6% | — | ||
| Q3 25 | -369.4% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 54.3% | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
净利率GOSSUSAS
| Q4 25 | -342.3% | — | ||
| Q3 25 | -362.7% | -82.3% | ||
| Q3 24 | — | -60.9% | ||
| Q2 24 | 51.4% | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
每股收益（稀释后）GOSSUSAS
| Q4 25 | $-0.21 | — | ||
| Q3 25 | $-0.21 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $0.22 | — | ||
| Q1 24 | $-0.19 | — | ||
| Q3 23 | $-0.21 | — | ||
| Q2 23 | $-0.45 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $136.9M | $39.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-122.8M | $50.2M |
| 总资产 | $172.2M | $234.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资GOSSUSAS
| Q4 25 | $136.9M | — | ||
| Q3 25 | $180.2M | $39.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | $354.5M | — | ||
| Q1 24 | $244.4M | — | ||
| Q3 23 | $328.9M | — | ||
| Q2 23 | $162.1M | — |
股东权益GOSSUSAS
| Q4 25 | $-122.8M | — | ||
| Q3 25 | $-82.3M | $50.2M | ||
| Q3 24 | — | $53.1M | ||
| Q2 24 | $81.5M | — | ||
| Q1 24 | $26.7M | — | ||
| Q3 23 | $104.6M | — | ||
| Q2 23 | $-62.8M | — |
总资产GOSSUSAS
| Q4 25 | $172.2M | — | ||
| Q3 25 | $208.8M | $234.7M | ||
| Q3 24 | — | — | ||
| Q2 24 | $373.4M | — | ||
| Q1 24 | $259.4M | — | ||
| Q3 23 | $347.9M | — | ||
| Q2 23 | $181.7M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-48.3M | $-12.5M |
| 自由现金流经营现金流 - 资本支出 | — | $-41.3M |
| 自由现金流率自由现金流/营收 | — | -216.5% |
| 资本支出强度资本支出/营收 | 0.0% | 150.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流GOSSUSAS
| Q4 25 | $-48.3M | — | ||
| Q3 25 | $-36.2M | $-12.5M | ||
| Q3 24 | — | $2.4M | ||
| Q2 24 | $116.3M | — | ||
| Q1 24 | $-52.3M | — | ||
| Q3 23 | $-34.5M | — | ||
| Q2 23 | $-38.3M | — |
自由现金流GOSSUSAS
| Q4 25 | — | — | ||
| Q3 25 | — | $-41.3M | ||
| Q3 24 | — | $-11.2M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
自由现金流率GOSSUSAS
| Q4 25 | — | — | ||
| Q3 25 | — | -216.5% | ||
| Q3 24 | — | -42.2% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
资本支出强度GOSSUSAS
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | 150.8% | ||
| Q3 24 | — | 51.2% | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
现金转化率GOSSUSAS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.36× | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
